Literature DB >> 30936149

Deficiency of ZnT8 Promotes Adiposity and Metabolic Dysfunction by Increasing Peripheral Serotonin Production.

Zhuo Mao1, Hui Lin1, Wen Su1, Jinghui Li1, Minsi Zhou1, Zhuoran Li1, Beibei Zhou2, Qing Yang1, Mingyan Zhou1, Ke Pan2, Jinhan He3, Weizhen Zhang4,5.   

Abstract

ZnT8 is a zinc transporter enriched in pancreatic β-cells, and its polymorphism is associated with increased susceptibility to type 2 diabetes. However, the exact role of ZnT8 in systemic energy metabolism remains elusive. In this study, we found that ZnT8 knockout mice displayed increased adiposity without obvious weight gain. We also observed that the intestinal tract morphology, motility, and gut microbiota were changed in ZnT8 knockout mice. Further study demonstrated that ZnT8 was expressed in enteroendocrine cells, especially in 5-hydroxytryptamine (5-HT)-positive enterochromaffin cells. Lack of ZnT8 resulted in an elevated circulating 5-HT level owing to enhanced expression of tryptophan hydroxylase 1. Blocking 5-HT synthesis in ZnT8-deficient mice restored adiposity, high-fat diet-induced obesity, and glucose intolerance. Moreover, overexpression of human ZnT8 diabetes high-risk allele R325W increased 5-HT levels relative to the low-risk allele in RIN14B cells. Our study revealed an unexpected role of ZnT8 in regulating peripheral 5-HT biogenesis and intestinal microenvironment, which might contribute to the increased risk of obesity and type 2 diabetes.
© 2019 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30936149     DOI: 10.2337/db18-1321

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

Review 1.  Loss of Znt8 function in diabetes mellitus: risk or benefit?

Authors:  Carla P Barragán-Álvarez; Eduardo Padilla-Camberos; Nestor F Díaz; Agustín Cota-Coronado; Claudia Hernández-Jiménez; Carlos C Bravo-Reyna; Nestor E Díaz-Martínez
Journal:  Mol Cell Biochem       Date:  2021-03-05       Impact factor: 3.396

Review 2.  Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management?

Authors:  Khalid Mehmood; Afrasim Moin; Talib Hussain; Syed Mohd Danish Rizvi; D V Gowda; Shazi Shakil; M A Kamal
Journal:  Folia Microbiol (Praha)       Date:  2021-10-26       Impact factor: 2.099

Review 3.  The gut microbiota and its interactions with cardiovascular disease.

Authors:  Hui Xu; Xiang Wang; Wenke Feng; Qi Liu; Shanshan Zhou; Quan Liu; Lu Cai
Journal:  Microb Biotechnol       Date:  2020-01-26       Impact factor: 5.813

Review 4.  Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.

Authors:  Zheng Zhou; Bao Sun; Dongsheng Yu; Chunsheng Zhu
Journal:  Front Cell Infect Microbiol       Date:  2022-02-15       Impact factor: 5.293

Review 5.  Potential Roles of Enterochromaffin Cells in Early Life Stress-Induced Irritable Bowel Syndrome.

Authors:  Enfu Tao; Zhenya Zhu; Chenmin Hu; Gao Long; Bo Chen; Rui Guo; Marong Fang; Mizu Jiang
Journal:  Front Cell Neurosci       Date:  2022-03-15       Impact factor: 5.505

Review 6.  Impact of Zinc Transport Mechanisms on Embryonic and Brain Development.

Authors:  Jeremy Willekens; Loren W Runnels
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

7.  Pancreatic β cell-selective zinc transporter 8 insufficiency accelerates diabetes associated with islet amyloidosis.

Authors:  Jie Xu; Nadeeja Wijesekara; Romario Regeenes; Dana Al Rijjal; Anthony L Piro; Youchen Song; Anne Wu; Alpana Bhattacharjee; Ying Liu; Lucy Marzban; Jonathan V Rocheleau; Paul E Fraser; Feihan F Dai; Cheng Hu; Michael B Wheeler
Journal:  JCI Insight       Date:  2021-05-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.